Timeliness of Health Technology Assessments and Price Negotiations for Oncology Drugs in Canada

Autor: Rawson NSB, Stewart DJ

Publikováno v: ClinicoEconomics and Outcomes Research, Vol Volume 16, Pp 437-445 (2024)

Nigel SB Rawson,1– 3 David J Stewart4,5 1Macdonald-Laurier Institute, Ottawa, Ontario, Canada; 2Canadian Health Policy Institute, Toronto, Ontario, Canada; 3Centre for Health Policy Studies, Fraser Institute, Vancouver, British Columbia, Canada; 4D

Externí odkaz: https://doaj.org/article/80efd78d319b4619997b4a4fb44bf00a

PIH9 A SIMULATION MODELING OF THE EFFECT OF DOSING SCHEDULE ON THE BENEFIT AND COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION IN CANADA

Autor: Ismaila, AS, Pereira, JA, Robson, RC, Rawson, NS, Simpson, SD, Standaert, BA

Publikováno v: In Value in Health 2009 12(3):A163-A163

The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health.

Autor: Balijepalli C; Pharmalytics Group, Vancouver, BC V6B 2Z4, Canada., Gullapalli L; Pharmalytics Group, Vancouver, BC V6B 2Z4, Canada., Joshy J; Pharmalytics Group, Vancouver, BC V6B 2Z4, Canada., Rawson NS; Canadian Health Policy Institute, Toronto, ON, Canada.; Macdonald-Laurier Institute, Ottawa, ON, Canada.

Publikováno v: Journal of comparative effectiveness research [J Comp Eff Res] 2024 May; Vol. 13 (5), pp. e230178. Date of Electronic Publication: 2024 Apr 03.

Health technology assessment of new drugs for rare disorders in Canada: impact of disease prevalence and cost.

Autor: Rawson NS; Eastlake Research Group, Oakville, ON, Canada. EastlakeRG@gmail.com.; Canadian Health Policy Institute, Toronto, ON, Canada. EastlakeRG@gmail.com.; Fraser Institute, Vancouver, BC, Canada. EastlakeRG@gmail.com.

Publikováno v: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2017 Mar 23; Vol. 12 (1), pp. 59. Date of Electronic Publication: 2017 Mar 23.

Health Canada's use of priority review status for drugs for unmet needs.

Autor: Rawson NS; Eastlake Research Group, Oakville, Ontario, Canada; Canadian Health Policy Institute, Toronto, Ontario, Canada. Electronic address: EastlakeRG@gmail.com.

Publikováno v: Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2015 Oct; Vol. 73 (1), pp. 391-5. Date of Electronic Publication: 2015 Aug 08.